Proteomic profiling of secretome derived from amniotic fluid stem cells reveals prioritized organs and therapeutic potentials for tissue regeneration, particularly supporting neuroregeneration

Amniotic fluid-derived MSCs (AFSCs) originate from fetal cells during a dynamic period of organogenesis, resulting in the secretion of a wide range of proteins that support tissue regeneration and organ function.